UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO
RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES
EXCHANGE ACT OF 1934
For the month
of August 2020
Commission File
Number: 001-38283
InflaRx
N.V.
(Translation of
registrant's name into English)
Winzerlaer Str.
2
07745 Jena,
Germany
(Address of principal executive
office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
☐
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
☐
INFLARX
N.V.
On August 6, 2020, InflaRx N.V.
issued a press release. A copy of the press release is attached
hereto as Exhibit 99.1 and is incorporated by reference
herein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
| |
INFLARX N.V.
|
| |
|
|
Date: August 6, 2020
|
By: |
/s/ |
Niels Riedemann
|
| |
Name:
|
Niels Riedemann
|
| |
Title:
|
Chief Executive Officer
|
EXHIBIT
INDEX
|
|
|
|
|
|
|
Press Release, dated August 6, 2020
|
